Skip to content

Provider profile

Northway Biotech.

Biologics CDMOs

Northway Biotech describes cell line and strain, process, analytical and formulation development and cGMP drug substance and drug product (fill and finish) manufacturing of antibodies and recombinant proteins from mammalian and microbial systems, plus plasmid DNA, viral vectors and cell therapies, for clinical and commercial supply. It lists biologics sites in Vilnius, Lithuania and Waltham, Massachusetts.

Website
northwaybiotech.com (opens in a new tab)
Sources reviewed
November 4, 2026 · Source pages re-checked within 4 months
First published
November 3, 2026

This profile summarizes what public sources state about the provider, mostly its own website. It is not an audit, qualification or endorsement by ArgusBio. Confirm capabilities directly with the provider before contracting.

Services and capabilities

Services and capabilities

  • Analytical development and QC testing1,4
  • Cell line development5,6
  • Formulation development7
  • GMP drug product manufacturing1,5,6In-house aseptic fill and finish: three lines across Vilnius and Waltham (vials, prefilled syringes, cartridges, lyophilization)
  • GMP drug substance manufacturing1,5
  • Lyophilization7Stated as liquid and lyophilized formulation development; lyophilization is also listed under aseptic fill and finish at both sites
  • Process development1,2,3
  • Stability studies8,9
  • Technology transfer1,8

Platforms and methods

  • Mammalian cell culture5,7
  • Microbial fermentation1,6,10Bacterial and yeast fermentation; microbial manufacturing up to 3,000 L working volume
  • Single-use bioreactors7,8Single-use mammalian bioreactors (10 L to 4,000 L in Vilnius; 10 L to 2,000 L in Waltham)

Drug substance / drug product

  • Drug product5,6
  • Drug substance1,5

Development experience

Development experience

Development stage

  • Commercial3,11
  • Phase 17Stated as team experience with S2 insect-cell expression programs, not as a company production record
  • Phase 27Stated as team experience with S2 insect-cell expression programs, not as a company production record
  • Phase 37Stated as team experience with S2 insect-cell expression programs, not as a company production record

Modality

  • Cell therapies1Autologous and allogeneic cell therapy development and cGMP manufacturing stated for a Vilnius facility
  • Gene therapies1,8Viral vector and plasmid DNA development and cGMP manufacturing stated for Vilnius
  • Monoclonal antibodies2,7
  • mRNA and nucleic acids8Plasmid DNA development and manufacturing; mRNA itself not documented
  • Recombinant proteins1,2

Locations

Locations

  • Vilnius, Lithuania · Manufacturing site5Biologics (mammalian single-use 10–4,000 L, microbial 10–4,500 L) drug substance and aseptic fill and finish; Vilnius also hosts the gene therapy (pDNA, viral vector) and cell therapy CDMO facilities
  • Waltham, United States · Manufacturing site6Waltham, Massachusetts: biologics (mammalian single-use 10–2,000 L, microbial 45–450 L) drug substance and aseptic fill and finish

Quality and regulatory

Quality and regulatory

The provider’s own materials state that it works to, or holds, the following. ArgusBio has not inspected or audited these claims.

  • GMP / cGMP1

Unknowns and questions to ask

Unknowns and questions to ask

Public sources rarely establish what matters most for a specific project. Confirm directly:

  • Available capacity, slot timing and scale for your next campaign
  • Recent experience with your specific modality and expression system or chemistry
  • Regulatory inspection history of the specific site that would manufacture your product
  • Technology-transfer approach, timeline and who owns the resulting process knowledge
  • Analytical and QC release testing done in-house versus subcontracted
  • Quality agreement terms, batch-failure responsibility and change-order mechanics

Choosing a CDMO: a practical guide

Evidence and sources

Evidence and sources

  1. 1cGMP Manufacturing | Northway Biotech (opens in a new tab)Northway Biotech · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  2. 2Cell Line & Strain Development Services | Northway Biotech (opens in a new tab)Northway Biotech · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  3. 3Microbial Biologics | Northway Biotech (opens in a new tab)Northway Biotech · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  4. 4Analytical Methods Development | Northway Biotech (opens in a new tab)Northway Biotech · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  5. 5Biologics CDMO Site | Vilnius, Lithuania | Northway Biotech (opens in a new tab)Northway Biotech · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  6. 6Biologics CDMO Site | Boston, MA | Northway Biotech (opens in a new tab)Northway Biotech · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  7. 7Mammalian Biologics | Northway Biotech (opens in a new tab)Northway Biotech · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  8. 8Process Development | Northway Biotech (opens in a new tab)Northway Biotech · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  9. 9Quality & Regulatory Support | Northway Biotech (opens in a new tab)Northway Biotech · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  10. 10Plasmid DNA Manufacturing | Northway Biotech (opens in a new tab)Northway Biotech · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  11. 11End-to-end Biologics CDMO | Northway Biotech (opens in a new tab)Northway Biotech · Provider website · retrieved November 3, 2026 · last checked November 3, 2026

“Last checked” means we confirmed the page was still available and still contained the cited statement. It does not mean ArgusBio verified the provider or its capabilities.

Something out of date or wrong? Request a correction. Corrections are reviewed against public sources before publication.

Contact

Contact

Contact the provider directly through its website (opens in a new tab). ArgusBio does not forward inquiries to providers and does not receive referral fees.

Compare with other biologics cdmos providers

ArgusBio sourcing

Need help evaluating this provider or comparing alternatives.

Discuss your sourcing need with ArgusBio. We can help define the scope, identify comparable alternatives and organize proposals so the decision stays yours.

Discuss a sourcing need

We work for the biotech, not the vendor. Vendors do not pay for inclusion or placement.